Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
May 18, 2016

Gaining Value from your Partner for Biomarker Research and Companion Diagnostics Development

Presented at Asian Regional Drug Development Summit on September 9, 2015, this presentation evaluates the trends and challenges in drug development across complex trials and reviews the importance of biomarker assay use and companion diagnostics (CDx) in drug development. This presentation will also highlight key biomarker and CDx case studies that demonstrate risk mitigation in drug development across various therapeutic areas and provide an overview of China CDx related regulatory. 

Download the presentation to learn more.

Yaozhou Shi, Ph.D., General Manager, Quest Diagnostics Clinical Trials China

Related Services:
Companion Diagnostics

Extensive expertise to accelerate your tandem development pathway

Planning and implementing biomarker testing for immuno-oncology trials

Exploring the challenges with the diverse clinical biomarker requirements

Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options

Read More